Abstract

BackgroundInfluenza, or “flu”, is an upper respiratory tract infectioncaused by a virus belonging to the family ofOrthomyxo-viridae. Influenza can pose a serious risk to the health ofmainly the elderly, the very young, and to people suffer-ing from medical conditions (e.g. weak immune system).For example, seasonal influenza strains are fatal to morethan 50,000 people annually in the United States alone[1]. The most effective measure for preventing influenza-related morbidity and mortality is annual vaccination.Seasonal influenza vaccines are almost exclusively pro-duced using the traditional egg-based manufacturing pro-cess. However, the main limitation of egg-basedtechnology (especially in the case of a pandemic) is thetime-consuming production process (~6 months).Furthermore, people with serious egg allergy cannot bevaccinated when trace amounts of egg protein remain inthe final formulation. Therefore, new production pro-cesses using continuous cell lines for influenza vaccinemanufacturing are currently being established [2].Influenza viruses take advantage of the host cell meta-bolism to replicate their genetic material and to synthe-size viral proteins. The influenza virus particle consistsof three major parts: the ribonucleocapsid, the matrixprotein M1, and the envelope, which is derived from theplasma membrane of the host cell. The lipid bilayer con-tains the ion channel protein M2 and the immunogenicglycoproteins hemagglutinin and neuraminidase [3]. Thereplication cycle of influenza viruses including entry,uncoating, genome transcription and replication, assem-bly and release has been studied extensively with type Astrains [4]. So far, only few studies have characterizedthe influence of influenza infection on the centralcarbon metabolism of host cells [5]. Madin-Darbycanine kidney (MDCK) cells are considered a suitablesubstrate for cell culture-based influenza vaccine manu-facturing [2,6]. In this study, key metabolic enzymeactivities were analyzed in MDCK cells infected with aninfluenza A virus strain to improve our understandingof virus-host cell interaction and cell response.Materials and methodsAll chemicals and enzymes were purchased from Sigma(Taufkirchen, Germany) or Roche (Mannheim, Ger-many). Adherent MDCK cells obtained from theECACC (No. 84121903) were routinely cultured in 6-well plates containing 4 mL of GMEM-based medium(2 mM glutamine, 30 mM glucose, 10 % (v/v) fetal calfserum, 2 g/L peptone, 48 mM NaHCO

Highlights

  • Influenza, or “flu”, is an upper respiratory tract infection caused by a virus belonging to the family of Orthomyxoviridae

  • Significant differences in catalytic activity between infected cells and mock-infected Madin-Darby canine kidney (MDCK) cells were found for 9 enzymes: glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase from the pentose phosphate pathway, glutaminase and malic

  • Experimental data clearly suggests a change in metabolism of cells infected with human influenza A (H1N1), i. e. an up-regulation of key metabolic enzyme activities in MDCK cells

Read more

Summary

Introduction

“flu”, is an upper respiratory tract infection caused by a virus belonging to the family of Orthomyxoviridae. Influenza can pose a serious risk to the health of mainly the elderly, the very young, and to people suffering from medical conditions (e.g. weak immune system). Seasonal influenza strains are fatal to more than 50,000 people annually in the United States alone [1]. The most effective measure for preventing influenzarelated morbidity and mortality is annual vaccination. Seasonal influenza vaccines are almost exclusively produced using the traditional egg-based manufacturing process. The main limitation of egg-based technology (especially in the case of a pandemic) is the time-consuming production process (~6 months). New production processes using continuous cell lines for influenza vaccine manufacturing are currently being established [2]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call